Jianbo Zhao Selected Research

Jianbo Zhao Research Topics

Disease

7	Fibrosis (Cirrhosis) 01/2024 - 09/2016
5	Ascites 05/2023 - 01/2019
4	Hemorrhage 08/2023 - 01/2019
4	Hepatocellular Carcinoma (Hepatoma) 05/2021 - 12/2015
3	Hepatic Encephalopathy 01/2024 - 01/2019
3	Portal Hypertension 01/2024 - 12/2015
2	Liver Diseases (Liver Disease) 12/2023 - 09/2016
2	Thrombosis (Thrombus) 10/2022 - 12/2015
2	Pain (Aches) 01/2022 - 09/2011
2	End Stage Liver Disease 12/2021 - 01/2021
2	Neoplasms (Cancer) 05/2021 - 12/2014
2	Inflammation (Inflammations) 05/2021 - 01/2021
2	Carcinogenesis 05/2021 - 12/2014
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2024
1	Sclerosing Cholangitis 12/2023
1	Autoimmune Hepatitis 12/2023
1	Ulcerative Colitis 02/2023
1	Sarcopenia 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022
1	Schistosomiasis (Bilharziasis) 10/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Necrosis 01/2022
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022
1	Chemical and Drug Induced Liver Injury 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2021
1	Chromosome Inversion (Chromosomal Inversion) 01/2021
1	Dehydration (Water Stress) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Heart Diseases (Heart Disease) 12/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Adenoma (Adenomas) 01/2015
1	Osteomyelitis 10/2013
1	Brain Ischemia (Cerebral Ischemia) 01/2013
1	Ischemia 01/2013
1	Focal Nodular Hyperplasia 09/2011
1	Lacrimal Apparatus Diseases (Epiphora) 04/2008

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2013
3	AlbuminsIBA 05/2023 - 01/2021
3	MicroRNAs (MicroRNA)IBA 12/2021 - 12/2014
2	Complement System Proteins (Complement)IBA 12/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2021 - 01/2013
2	Ethiodized Oil (Ethiodol)FDA Link 07/2017 - 09/2011
1	Pyrrolizidine AlkaloidsIBA 01/2024
1	Complement C1q (C1q Complement)IBA 12/2023
1	Complement Factor H (Factor H)IBA 12/2023
1	Polysaccharides (Glycans)IBA 02/2023
1	CalciumIBA 06/2022
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 06/2022
1	indium-bleomycinIBA 06/2022
1	des-Arg-(77)- complement C3aIBA 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	Complement C4 (Complement Component 4)IBA 01/2022
1	Complement C5 (Complement 5)IBA 01/2022
1	CreatinineIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Complement Factor B (Factor B)IBA 01/2022
1	Complement Factor D (Factor D)IBA 01/2022
1	AntipyreticsIBA 01/2022
1	SodiumIBA 12/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2021
1	Circular RNAIBA 12/2021
1	CateninsIBA 05/2021
1	Protein Kinases (Protein Kinase)IBA 05/2021
1	FructoseIBA 01/2021
1	EnzymesIBA 01/2021
1	LeukotrienesIBA 01/2021
1	AluminumIBA 01/2021
1	malic acid (malate)IBA 01/2021
1	CytokinesIBA 01/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Interleukin-17 (Interleukin 17)IBA 01/2015
1	MagnesiumIBA 10/2013
1	zileuton (Zyflo)FDA Link 01/2013
1	Polyvinyl AlcoholIBA 09/2011
1	EmulsionsIBA 09/2011
1	bleomycetinIBA 09/2011

Therapy/Procedure

11	Transjugular Intrahepatic Portasystemic Shunt 01/2024 - 12/2015
7	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2024 - 12/2015
1	Drug Therapy (Chemotherapy) 07/2017
1	Contraindications 09/2016
1	Debridement 10/2013
1	Aftercare (After-Treatment) 04/2008